KRYSTAL LYNN MORGAN
Allopathic & Osteopathic Physicians|Family Medicine CRANDALL, TX NPI 1992363428
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine TX ABBVIE INC. All categories
General Payments — all program years on this page
$1,175.02
- Category: General Payments
- Program years: PY2021–2023
- Record count: 71
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $152.77 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $152.77 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $67.70 | 3 |
| Novo Nordisk AS | $37.47 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.78 | 1 |
| Mylan Specialty L.P. | $15.74 | 1 |
| Acerta Pharma LLC | $14.08 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1005876555 | Novo Nordisk Inc | $16.08 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1005876561 | Novo Nordisk Inc | $21.39 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1006263987 | ABBVIE INC. | $29.88 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1006263991 | ABBVIE INC. | $23.70 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1006263993 | ABBVIE INC. | $14.12 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1025047263 | AstraZeneca Pharmaceuticals LP | $14.08 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1039071349 | Mylan Specialty L.P. | $15.74 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 996618129 | Boehringer Ingelheim Pharmaceuticals, Inc. | $17.78 | 08/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.